Pfizer Inc.  

(Public, NYSE:PFE)   Watch this stock  
Find more results for PFE
28.72
-0.39 (-1.34%)
Real-time:   10:06AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 28.68 - 28.92
52 week 21.40 - 31.15
Open 28.86
Vol / Avg. 3.07M/37.94M
Mkt cap 203.72B
P/E 20.36
Div/yield 0.24/3.34
EPS 1.41
Shares 7.09B
Beta 0.74
Inst. own 74%
Jul 29, 2013
Q2 2013 Pfizer Earnings Release Add to calendar
Apr 30, 2013
Q1 2013 Pfizer Earnings Conference Call - Webcast
Apr 29, 2013
Q1 2013 Pfizer Earnings Release
Apr 25, 2013
Pfizer Annual Shareholder Meeting
Apr 23, 2013
Pfizer at Biotechnology Industry Organization (BIO) International Convention
Feb 26, 2013
Pfizer at Citi Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 20.45% 16.14%
Operating margin 29.04% 20.48%
EBITD margin - 44.42%
Return on average assets 5.93% 5.09%
Return on average equity 13.44% 11.62%
Employees 91,500 -
Carbon Disclosure Rating - 87/100

Address

235 East 42nd Street
NEW YORK, NY 10017-5755
United States - Map
+1-212-7332323 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia
Discussion Group - Google Finance

Description

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. The Company�s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. On August 1, 2011, it completed the sale of its Capsugel business. In October 2011, it acquired Icagen, Inc. In December 2011, it acquired the consumer healthcare business of Ferrosan Holding A/S. In December 2011, it acquired Excaliard Pharmaceuticals, Inc. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc.

Officers and directors

Ian C. Read Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Frank A. D'Amelio Chief Financial Officer, Executive Vice President - Business Operations
Age: 55
Bio & Compensation  - Reuters
Mikael Dolsten M.D., Ph.D. President - Worldwide Research and Development
Age: 54
Bio & Compensation  - Reuters
Douglas M. Lankler Executive Vice President, Chief Compliance and Risk Officer
Age: 47
Bio & Compensation  - Reuters
Amy W. Schulman Executive Vice President, General Counsel, Business Unit Lead - Consumer Healthcare
Age: 52
Bio & Compensation  - Reuters
Charles H. Hill III Executive Vice President - Worldwide Human Resources
Age: 57
Bio & Compensation  - Reuters
Freda C. Lewis-Hall M.D. Executive Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters
Anthony J. Maddaluna Executive Vice President; President, Pfizer Global Supply
Age: 60
Bio & Compensation  - Reuters
Laurie J. Olson Executive Vice President - Strategy, Portfolio and Commercial Operations
Age: 49
Bio & Compensation  - Reuters
Sally Susman Executive Vice President - Policy, External Affairs and Communications
Age: 51
Bio & Compensation  - Reuters